Clients
Bayer AGBayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. The company’s products and services are designed to benefit people and improve their quality of life. At the same time Bayer creates value through innovation, growth and high earning power.
The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2010, Bayer employed 111,400 people and had sales of €35.1 billion. Capital expenditures amounted to €1.6 billion, R&D expenses to €3.1 billion. |
 www.bayer.com   
|
News
Deutsche Bank Seeks to Avoid Law Suits With Board Changes
Tue, 21 May 2013 22:01:24 GMT
Regeneron, Sanofi asthma drug seen as potential game changer
Tue, 21 May 2013 12:14:56 GMT
German stocks - Factors to watch on May 21
Tue, 21 May 2013 05:07:03 GMT
Regeneron settles all pending litigation with Roche's Genentech
Mon, 20 May 2013 22:26:10 GMT
Bayer says lung drug shows promise in prolonged trial
Mon, 20 May 2013 19:00:00 GMT
EU watchdog backs Bayer acne drug for certain patients
Fri, 17 May 2013 11:34:57 GMT
[$$] Dow Chemical to Appeal Judgment
Thu, 16 May 2013 18:08:44 GMT
Bayer to acquire herbal medicine maker Steigerwald
Thu, 16 May 2013 11:41:47 GMT
Algeta Surges to Record After Prostate Cancer Drug Approval
Thu, 16 May 2013 07:54:35 GMT
German stocks - Factors to watch on May 16
Thu, 16 May 2013 05:29:43 GMT
NORDIC STOCKS - Factors to watch on May 16
Thu, 16 May 2013 05:10:54 GMT
[$$] Bayer Gets FDA Approval for Advanced Prostate Cancer Drug
Wed, 15 May 2013 22:15:23 GMT
Bayer, Algeta win FDA approval for prostate cancer drug
Wed, 15 May 2013 15:35:12 GMT
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
Wed, 15 May 2013 14:38:16 GMT
German chemical sector still sees 2 pct growth in 2013
Wed, 15 May 2013 08:00:01 GMT
Bayer starts Phase III trial on regorafenib in liver cancer
Wed, 15 May 2013 06:45:23 GMT
U.S. urged to take tougher line on Indian trade practices
Tue, 14 May 2013 20:37:05 GMT
A taste for defensives sours prospects for European stocks
Tue, 14 May 2013 11:32:06 GMT
Bayer Communications Chief Schade to Run Leverkusen Soccer Club
Tue, 14 May 2013 09:12:27 GMT
Hospital to probe East German medical trials
Mon, 13 May 2013 19:17:45 GMT